MB Diagnostics ApS: Financial statements 2021
CVR: 38185853
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
MB Diagnostics ApS (CVR 38185853) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 42,932 and a net result of DKK 21,690 compared with DKK -20,019 the year before. Equity in the 2021 report amounted to DKK 828,227. The solvency ratio was 69%.
- Gross Profit
- DKK 42,932
- Profit/Loss
- DKK 21,690
- Equity
- DKK 828,227
- Total Assets
- DKK 1,201,035
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 43 t. | 22 t. | 828 t. | 0 |
| 2020 | - | -9 t. | -20 t. | 807 t. | 0 |
| 2019 | - | 586 t. | 448 t. | 827 t. | 0 |
| 2018 | - | 645 t. | 491 t. | 379 t. | 0 |
Official annual report
Find more companies like MB Diagnostics ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
MB Diagnostics ApS has published its annual report for 2020. Gross profit came to DKK -8,625, and the net result was DKK -20,019.
About MB Diagnostics ApS
MB Diagnostics ApS is a Danish company of the type Anpartsselskab based in Nærum, founded in 2016. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The management consists of Mikael Ploug Boesen. The company is owned by Mikael Ploug Boesen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,000 and a net result of DKK -23,026 compared with DKK -15,293 the year before. Equity in the 2025 report amounted to DKK 566,629.